Proteome Systems (ASX:PXL) has been awarded a $2 million START grant by the Australian Government to progress the development of its new, improved diagnostic for tuberculosis (TB). The TB test under development by Proteome Systems is rapid and simple to perform compared to the alternatives in current use. It identifies TB proteins, which are detectable in a patient during active infection.
